Freeman and collaborators (1) report in the current issue of the Journal of Lipid Research important findings indicating that cholesterol-loaded macrophages secrete unesterified cholesterol (UC) complexes that are deposited as microdomains within the cell surface of the macrophages, as well as in their secreted extracellular matrix (ECM). Furthermore, the experiments indicate that these microdomains participate in the initial steps of the reverse-cholesterol pathways (1). The UC-microdomains are rich in cholesterol monohydrate aggregates that are recognized by MAb 58B1, an antibody generated against cholesterol crystals and that specifically recognizes ordered arrays with a minimum of 12 cholesterol monohydrate molecules (2). Deposition of the ECM and cell surface UC-cholesterol microdomains required overloading of macrophages with cholesterol as well as functional ABCA1 and ABCG1 transporters (3). Importantly, Freeman et al. show that the deposition of cholesterol-rich microdomains in the macrophage's surface and in the ECM as a consequence of acetylated (Ac)-LDL loading could be inhibited by the presence of 50 μg/ml apoAI in the incubation. However, when intact HDL was used at a similar concentration, it did not inhibit deposition of the UC-microdomains in the cell surface, although this did occur when HDL was used at a concentration of 200 μg/ml.